Dr. Reddy's Labs Unveils Renvela Generic Sevelamer Carbonate In U.S
(RTTNews.com) - Dr. Reddy's Laboratories Ltd. (RDY, DRREDDY) announced Thursday the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets.
It is a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for Oral Suspension, approved by the U.S. Food and Drug Administration.
Renvela is a trademark of French drug giant Sanofi (SNYNF, SNY).
Dr. Eddy's noted that the Renvela brand and generic had U.S. sales of approximately $101 million MAT for the most recent twelve months ending in October 2018, according to IMS Health.
Dr. Reddy's Sevelamer Carbonate for Oral Suspension is available in 0.8 g and 2.4 g packets in count size of 90.
Read the original article on RTTNews (http://www.rttnews.com/2965465/dr-reddy-s-labs-unveils-renvela-generic-sevelamer-carbonate-in-u-s.aspx)
For comments and feedback: contact firstname.lastname@example.org
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.